Upstream Biotechnology, Inc.
PrivateLast Round
Seed
Jul 28, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Upstream Biotechnology, Inc. operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Seed round in July 2026.
Upstream Biotechnology, Inc. is an agricultural biotechnology company that develops programmable translational control technologies and seed traits to enhance crop disease resistance and resilience.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Upstream Biotechnology, Inc. Comparables
Compare Upstream Biotechnology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneNeer | 78% | |
| Terrana Biosciences | 77% | |
| AgriRNA Biosciences | 76% |
For institutional investors. Book with your work email.
Upstream Biotechnology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 28, 2026 | ||||
| Seed | Jul 28, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Upstream Biotechnology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LeVert Ventures | Seed |
| Corteva Catalyst | Seed |
| SilverBlue | Seed |
| VTC Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 181% MoM, reaching 1.9K.
- Jul 28, 2026
Led by LeVert Ventures with participation from VTC Ventures and Corteva Catalyst.
For institutional investors. Book with your work email.
Upstream Biotechnology, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Upstream Biotechnology, Inc.'s valuation, stock price, and market status.
Is Upstream Biotechnology, Inc. a public or private company?
Upstream Biotechnology, Inc. is a private company.
What is the current stock price of Upstream Biotechnology, Inc.?
Upstream Biotechnology, Inc. is a private company, so its shares have no public market price. Caplight tracks Upstream Biotechnology, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Upstream Biotechnology, Inc. worth (valuation)?
Valuation information for Upstream Biotechnology, Inc. is not publicly available.
Can I buy Upstream Biotechnology, Inc. stock?
Upstream Biotechnology, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Upstream Biotechnology, Inc.'s last funding round?
Upstream Biotechnology, Inc.'s most recent funding round was Seed on July 28, 2026.
Who are the main investors in Upstream Biotechnology, Inc.?
Key investors in Upstream Biotechnology, Inc. include LeVert Ventures.
Will Upstream Biotechnology, Inc. IPO soon?
No public IPO plans have been announced for Upstream Biotechnology, Inc..
How can I track Upstream Biotechnology, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Upstream Biotechnology, Inc.'s shares on secondary markets.